AutoInflammatory Disease Alliance Registry (AIDA)

Plain-language summary

This is a registry study that collects information from patients with autoinflammatory diseases; no treatment is given. It enrolls patients diagnosed with a range of autoinflammatory conditions, such as familial Mediterranean fever, Behçet's disease, Still's disease, and non-infectious uveitis. It is a study with no assigned phase and is currently recruiting participants.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Recruiting

Sponsor

University of Siena

Intervention

No intervention is foreseen by the protocol.

Start date

8/6/2020

Estimated completion

8/6/2030

Countries

Algeria, Australia, Belgium, Brazil, China, Colombia, Egypt, Germany, Greece, India, Iran, Italy, Libya, Martinique, Mexico, Poland, Romania, Saudi Arabia, Spain, Tunisia, Turkey (Türkiye), Ukraine

Related genes

Locations

• Algiers, Algeria
• Boumerdas, Algeria
• Adelaide, Australia
• Adelaide, Australia
• Antwerp, Belgium
• São Paulo, Brazil
• Beijing, China
• Chongqing, China
• Bogotá, Colombia
• Al Mansurah, Egypt
• Cairo, Egypt
• Cairo, Egypt
• Lübeck, Germany
• Athens, Greece
• Athens, Greece
• Athens, Greece
• Bangalore, India
• Chandigarh, India
• Tehran, Iran
• Siena, Italy
• Bari, Italy
• Bari, Italy
• Bari, Italy
• Bari, Italy
• Bari, Italy
• Bolzano, Italy
• Brescia, Italy
• Brescia, Italy
• Cagliari, Italy
• Catania, Italy
• Catania, Italy
• Catanzaro, Italy
• Chieti, Italy
• Civitavecchia, Italy
• Ferrara, Italy
• Florence, Italy
• Florence, Italy
• Florence, Italy
• Florence, Italy
• Florence, Italy

+72

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* to be diagnosed with a monogenic AID according to the clinical phenotype and the detection of a confirmative genotype;
* to be diagnosed with clinical familial Mediterranean fever or Behçet's disease or Still disease or PFAPA syndrome or Schnitzler's disease or CRMO according to the corresponding clinical diagnostic and/or classification criteria;
* to be diagnosed with undifferentiated systemic AID;
* to be diagnosed with non-infectious uveitis according to the standardization for uveitis nomenclature (SUN) criteria;
* to be diagnosed with anterior or posterior non-infectious scleritis;
* to be diagnosed with spondyloarthritis according to ASAS and/or New York criteria;
* to be diagnosed with Castleman disease;

Exclusion Criteria:

\- informed consent/assent not provided by the patient and/or his/her legal representative.